I
Immunome, Inc. (IMNM)
NCM – Real Time Price. Currency in USD
22.69
-0.31 (-1.35%)
At close: May 12, 2026, 4:00 PM EDT
22.75
+0.06 (0.26%)
After-hours: May 12, 2026, 5:07 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
22.69
-0.31 (-1.35%)
At close: May 12, 2026, 4:00 PM EDT
22.75
+0.06 (0.26%)
After-hours: May 12, 2026, 5:07 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 14.69 | 6.05 | 10 | |
| Quick ratio | 14.69 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 14M | 9M | 7M | 7M |
| Gross Profit | -631K | 13M | 7M | 4M | 4M |
| Operating Income | -37M | -110M | -153M | -214M | -214M |
| Net Income | -37M | -107M | -293M | -212M | -212M |
| EBITDA | -36M | -109M | -151M | -211M | -211M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -92.41 | -6.95 | 1.0 |
| Next quarter | -94.47 | -19.38 | 1.0 |
| Current year | -30.73 | 0.12 | 1.5 |
| Next year | 1440.69 | 10.75 | 8.5 |
| Weighted average score | 3.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -21.65 | -16.91 | -24.8 | 3.3 |
| Y/Y | -99.99 | 12.9 | 31.53 | -20.29 | 5.0 |
| 3y average | 313.43 | -112.07 | -5.2 | -434.52 | 3.3 |
| 5y average | 587.66 | -84.81 | -0.13 | -281.1 | 3.3 |
| Weighted average score | 3.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $653.5M significantly exceed its total debt $3.9M, ensuring strong financial flexibility
Total current assets $660.8M exceed Total current liabilities $45.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$52.0M limits the company's ability to reinvest or pay down debt